CROSSJECT - Public Comps and Valuation Multiples

CROSSJECT Overview

About CROSSJECT

CROSSJECT manufactures and markets needle-free drug self-injection system.

Founded

2002

HQ

Employees

Website

crossject.com

Sectors

Medical Devices

Financials

LTM Revenue $10.8M

LTM EBITDA -$5.7M

EV

$156M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

CROSSJECT Financials

As of September 2025, CROSSJECT reported last 12-month revenue of $10.8M and EBITDA of -$5.7M.

In the same period, CROSSJECT achieved -$6.8M in LTM net income.

See CROSSJECT valuation multiples based on analyst estimates

CROSSJECT P&L

In the most recent fiscal year, CROSSJECT reported EBITDA of -$10.8M.

CROSSJECT expects next 12-month revenue of XXX and NTM EBITDA of XXX

See CROSSJECT valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$10.8M	XXX	n/a	XXX	XXX	XXX
Gross Profit	n/a	XXX	-$10.7M	XXX	XXX	XXX
Gross Margin	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA	-$5.7M	XXX	-$10.8M	XXX	XXX	XXX
EBITDA Margin	-52%	XXX	n/a	XXX	XXX	XXX
EBIT	-$8.3M	XXX	-$15.0M	XXX	XXX	XXX
EBIT Margin	-76%	XXX	n/a	XXX	XXX	XXX
Net Profit	-$6.8M	XXX	-$14.8M	XXX	XXX	XXX
Net Margin	-63%	XXX	n/a	XXX	XXX	XXX
Net Debt	XXX	XXX	$16.2M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for CROSSJECT including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $10.8M. EBITDA for the last twelve months was -$5.7M.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$10.8M	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	-$10.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	-$5.7M	Analyst estimates available to subscribers	-$10.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	-52.5% EBITDA margin	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	-$8.3M	Analyst estimates available to subscribers	-$15.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	-76.3% EBIT margin	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$6.8M	Analyst estimates available to subscribers	-$14.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-62.6% net profit margin	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$16.2M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for CROSSJECT

This financial data table provides comprehensive performance metrics for CROSSJECT, a company based in France. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

CROSSJECT generated $10.8M in revenue over the last twelve months.
The company achieved -$5.7M in EBITDA over the last twelve months.
Net income over the last twelve months reached -$6.8M.

Fiscal Year Performance

Fiscal year EBITDA was -$10.8M.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for CROSSJECT. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

CROSSJECT Stock Performance

CROSSJECT has current market cap of EUR 121M (or $140M), and EV of EUR 135M (or $156M).

Market Cap Evolution

CROSSJECT Stock Data

As of October 17, 2025, CROSSJECT's stock price is EUR 2 (or $3).

See CROSSJECT trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$156M	$140M	XXX	XXX	XXX	XXX	$-0.15

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

CROSSJECT Valuation Multiples

CROSSJECT's trades at 932.8x EV/Revenue multiple, and -14.5x EV/EBITDA.

See valuation multiples for CROSSJECT and 15K+ public comps

CROSSJECT Financial Valuation Multiples

As of October 17, 2025, CROSSJECT has market cap of $140M and EV of $156M.

Equity research analysts estimate CROSSJECT's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

CROSSJECT has a P/E ratio of -20.6x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$140M	XXX	$140M	XXX	XXX	XXX
EV (current)	$156M	XXX	$156M	XXX	XXX	XXX
EV/Revenue	14.4x	XXX	932.8x	XXX	XXX	XXX
EV/EBITDA	-27.5x	XXX	-14.5x	XXX	XXX	XXX
EV/EBIT	-18.9x	XXX	-10.4x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	-20.6x	XXX	-9.5x	XXX	XXX	XXX
EV/FCF	-19.6x	XXX	-11.8x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get CROSSJECT Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

CROSSJECT Margins & Growth Rates

CROSSJECT's last 12 month revenue growth is 121%

CROSSJECT's revenue per employee in the last FY averaged n/a, while opex per employee averaged $0.1M for the same period.

CROSSJECT's rule of 40 is -4911% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

CROSSJECT's rule of X is 250% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for CROSSJECT and other 15K+ public comps

CROSSJECT Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	121%	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	-52%	XXX	n/a	XXX	XXX	XXX
EBITDA Growth	-128%	XXX	n/a	XXX	XXX	XXX
Rule of 40	-4911%	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	250%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	n/a	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial